HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Walter Elisei Selected Research

Diverticulitis

6/2022Performance of a multicompounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease.
1/2022Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study.
12/2019What's New in Diagnosing Diverticular Disease.
3/2019Diverticulosis today.
9/2018Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
10/2016Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
10/2016Prognostic Role of the Endoscopic Classification "DICA".
8/2016Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study.
1/2016Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis.
9/2014Chronic diverticulitis and Crohn's disease share the same expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Walter Elisei Research Topics

Disease

15Diverticular Diseases
01/2020 - 03/2006
13Diverticulitis
06/2022 - 09/2007
13Ulcerative Colitis
02/2022 - 10/2010
11Crohn Disease (Crohn's Disease)
02/2022 - 06/2006
9Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2022 - 11/2013
5Inflammation (Inflammations)
03/2021 - 01/2009
5Abdominal Pain (Pain, Abdominal)
09/2018 - 03/2015
3Diverticulum
10/2016 - 12/2011
3Necrosis
09/2014 - 12/2011
3Infections
06/2012 - 04/2007
3Celiac Disease (Celiac Sprue)
10/2009 - 07/2005
2Pain (Aches)
03/2015 - 01/2015
2Colitis
12/2011 - 08/2005
1Dyspepsia (Indigestion)
01/2021
1Gastroesophageal Reflux (GERD)
01/2021
1Hypertension (High Blood Pressure)
01/2020
1Colonic Polyps
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Type I Syndactyly
09/2014
1Fever (Fevers)
08/2014
1Colonic Diverticulitis
08/2014
1Ulcer
07/2013
1Peptic Ulcer (Peptic Ulcers)
08/2011
1Gastritis
08/2011
1Habitual Abortion (Recurrent Miscarriage)
11/2008
1Reperfusion Injury
12/2005
1Fibrosis (Cirrhosis)
12/2005
1End Stage Liver Disease
12/2005
1Hyperoxia
02/2005

Drug/Important Bio-Agent (IBA)

10Infliximab (Remicade)FDA Link
02/2022 - 07/2013
9Leukocyte L1 Antigen Complex (Calgranulin)IBA
06/2022 - 01/2009
9Mesalamine (Mesalazine)FDA LinkGeneric
12/2019 - 04/2006
7Adalimumab (Humira)FDA Link
05/2022 - 01/2014
4Biosimilar PharmaceuticalsIBA
05/2022 - 12/2017
4C-Reactive ProteinIBA
10/2016 - 08/2014
3CT-P13IBA
02/2022 - 12/2017
3Proton Pump InhibitorsIBA
01/2021 - 08/2011
3Rifaximin (L 105)FDA Link
12/2019 - 04/2006
3Budesonide (Pulmicort)FDA LinkGeneric
12/2019 - 06/2006
3Pharmaceutical PreparationsIBA
10/2016 - 09/2007
2golimumabFDA Link
12/2021 - 09/2017
2SteroidsIBA
01/2021 - 06/2006
2Anti-Bacterial Agents (Antibiotics)IBA
03/2019 - 01/2016
2AntibodiesIBA
05/2015 - 09/2014
2Syndecan-1 (Syndecan 1)IBA
09/2014 - 09/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2014 - 09/2014
2Clarithromycin (Biaxin)FDA LinkGeneric
06/2012 - 08/2011
2Beclomethasone (Beclometasone)FDA Link
06/2006 - 08/2005
1GP2017IBA
05/2022
1antineoplaston A10 (A 10)IBA
01/2022
1Ustekinumab (CNTO 1275)FDA Link
01/2021
1gingerolIBA
01/2021
1Angiotensin Receptor AntagonistsIBA
01/2020
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
01/2020
1SmokeIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
12/2019
1vedolizumabIBA
08/2019
1Interleukin-10 (Interleukin 10)IBA
12/2018
1Vitamin DFDA LinkGeneric
12/2016
1Levofloxacin (Levaquin)FDA Link
06/2012
1BismuthIBA
06/2012
1TinidazoleFDA Link
08/2011
1Amoxicillin (Wymox)FDA LinkGeneric
08/2011
1Fibrinogen (Factor I)FDA Link
11/2010
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2010
1balsalazide (Colazal)FDA LinkGeneric
09/2007
1LactoferrinIBA
04/2007
1LactoseFDA LinkGeneric
03/2006
1Lactulose (Duphalac)FDA LinkGeneric
03/2006
1OxysterolsIBA
12/2005
1cholest-5-en-3 beta,7 alpha-diolIBA
12/2005

Therapy/Procedure

11Therapeutics
03/2021 - 04/2006
3Gluten-Free Diet
10/2009 - 07/2005
2Aftercare (After-Treatment)
12/2011 - 01/2009
2Liver Transplantation
12/2005 - 02/2005
1Appendectomy
01/2020